Share class: Gerresheimer AG

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A134,540,00034,540,000 ( 100.00 %) 0 100.00 %

Major shareholders: Gerresheimer AG

NameEquities%Valuation
NN Group NV
9.966 %
3,442,229 9.966 % 394 M €
Goldman Sachs Asset Management BV (Old)
8.392 %
2,898,689 8.392 % 332 M €
Teacher Retirement System of Texas
3.004 %
1,037,459 3.004 % 119 M €
Schroder Investment Management Ltd.
2.957 %
1,021,344 2.957 % 117 M €
Artisan Partners LP
2.953 %
1,019,835 2.953 % 117 M €
AllianceBernstein LP
2.657 %
917,628 2.657 % 105 M €
Norges Bank Investment Management
2.567 %
886,651 2.567 % 102 M €
DWS Investment GmbH
2.476 %
855,266 2.476 % 98 M €
MFS International Singapore Pte Ltd.
1.594 %
550,633 1.594 % 63 M €
Amundi Asset Management SA (Investment Management)
1.319 %
455,553 1.319 % 52 M €
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░

Breakdown by shareholder type

Institutional38.64%
NN Group NV9.97%
Unknown51.39%

Based on 1000 largest holdings

Geographical origin of shareholders

Netherlands 18.36%
United States 9.34%
Germany 6.22%
United Kingdom 4.88%
France 2.81%
Norway 2.59%
Singapore 1.59%
Belgium 0.84%
Denmark 0.53%
Luxembourg 0.53%
Spain 0.22%
Austria 0.21%
Ireland 0.18%
Finland 0.14%
Switzerland 0.09%
Canada 0.03%
South Africa 0.02%
Mexico 0.01%
Slovenia 0.01%

Based on 1000 largest holdings

Logo Gerresheimer AG
Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The Company operates approximately 40 production facilities in Europe, North America, South America and Asia.
Employees
11,913
More about the company
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities. Last hours!
BENEFIT NOW